SCHEMBL845030

SCHEMBL845030

CN1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)[C@@H]3CCCN3C)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
HTT P42858 2/20 0.49
MAPK1 P28482 2/20 0.49
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
NPC1 O15118 1/20 0.47
PABPC1 P11940 1/20 0.47
EP300 Q09472 2/20 0.45
CREBBP Q92793 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
TSHR P16473 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
POLB P06746 1/20 0.44
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL844884 0.86 HTT (0.48) ALDH1A1HTTMAPK1CYP2C9CYP2C19
SCHEMBL845255 0.85 CYP2C9 (0.47) ALDH1A1HTTMAPK1CYP2C9CYP2C19
SCHEMBL845258 0.82 MAPK1 (0.60) ALDH1A1HTTMAPK1CYP2C9CYP2C19
SCHEMBL844890 0.81 KCNH2 (0.51) ALDH1A1HTTMAPK1CYP2C9CYP2C19
SCHEMBL844894 0.81 CYP2C19 (0.55) ALDH1A1HTTMAPK1CYP2C9CYP2C19
SCHEMBL844919 0.81 NPC1 (0.54) ALDH1A1HTTMAPK1CYP2C9CYP2C19
SCHEMBL845774 0.81 CYP2C19 (0.49) ALDH1A1HTTMAPK1CYP2C9CYP2C19
SCHEMBL845251 0.81 PABPC1 (0.50) ALDH1A1HTTMAPK1CYP2C9CYP2C19
SCHEMBL845488 0.81 CYP2C19 (0.48) ALDH1A1HTTMAPK1CYP2C9CYP2C19
SCHEMBL845202 0.81 CYP2C19 (0.48) ALDH1A1HTTMAPK1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed